KushCo Holdings (OTCQX:KSHB) announced Monday (July 8) that it has filed to list its common shares on the NASDAQ Global Select Market.

The California-based cannabis company will continue to be traded on the OTCQX until its application to list on the NASDAQ has been approved. The move is an important step for the company as it establishes itself in the growing US cannabis market. KushCo became qualified to trade on OTC Market Group’s Best Market earlier this year after trading on the OTCQB Venture Market since 2016.

In a press release, KushCo Chairman and CEO Nick Kovacevich said that getting listed on the NASDAQ would raise the company’s profile by diversifying its shareholder base and “enhancing share liquidity” to support the company’s goals in the long term.

“If anybody can uplist, we certainly have a good opportunity to do so,” said KushCo CFO Jason Vegotsky in a previous interview with the Investing News Network.

The move comes after the company reported a new partnership with C.A. Fortune, a product sales and marketing agency that focuses on lifestyle brands, earlier this month. C.A. Fortune’s reach into retail channels will provide KushCo with increased access as it expands into the cannabidiol (CBD) retail space.

KushCo also announced a new 40,000 square foot distribution facility in Taylor, Michigan, last month that will support operations in the Midwest with the recent legalization of recreational cannabis use in both Michigan and Illinois.

The company’s subsidiaries and brands manufacture cannabis vaporizer products, supplies and accessories, and provide the larger cannabis sector with hydrocarbon gases and solvents. Since its founding in 2010, KushCo has offered its services to over 6,000 cannabis producers and processors across North and South America and Europe.

KushCo’s Q2 results hit a company record for quarterly revenue. Net revenue increased 240 percent year-over-year to US$35.2 million compared to US$10.4 million in the same quarter last year.

KushCo’s status as an ancillary company in the cannabis industry allowed it to apply for the move onto the NASDAQ. While there are several states in the US that have legalized cannabis for either medical or recreational use, the substance’s federal status as a Schedule I drug prevents the NASDAQ and the NYSE from listing companies that deal directly with cannabis plants and do business in the US.

KushCo’s share price increased about 3.5 percent after Monday’s announcement, ending the day at US$5.22. The company opened at US$5.30 on Tuesday (July 9) and closed at US$5.11.

TipRanks has a price target for the company of US$7.90, representing upside of over 50 percent.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (“ HempFusion ” or the “ Company ”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly owned subsidiary, Probulin Probiotics, LLC (“ Probulin ”), has increased its product selection in certain brick and mortar locations and expanded its distribution on Amazon through a unique eCommerce store within the Amazon platform. The broader product selection is available in major brick and mortar stores including Sprouts and Fresh Thyme and includes the Company’s new Probulin Total Care Immune product.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005411/en/

Keep reading... Show less